News | September 07, 2024
Aster CMI Hospital and Coal India provide bone marrow transplants
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
Subscribe To Our Newsletter & Stay Updated
